Hunter Medical Research Institute
This location is 20 minutes’ drive from main venue. Bus transport is provided and will return to the Newcastle City Hall once both sessions are finished - see the bus and session timetable.
- 1:45 pm, Monday 14 May
- 8:30 am, Tuesday 15 May
- 1:00 pm, Tuesday 15 May
Jane Gray, Executive Director, Research, Innovation and Partnerships
Emeritus Professor Maree Gleeson, Interim Director, NSW Regional Health Partners (NHMRC Accredited Centre for
Innovation in Regional Health) and Non-Executive Director, Boards of Central Coast Local Health District, NSW Health
Pathology and Hunter Water Corporation
Assoc Prof Luke Wolfenden, Associate Professor, School of Medicine and Public Health, University of Newcastle
Health Services Manager, Hunter New England Population Health
Dr Lee Fong, Clinical Editor and Clinical Lead, Hunter New England HealthPathways
- Executive sponsors
- Programme managers
- Clinical leads*
- Clinical editors*
In this session you will enjoy four presentations from local change-makers and clinicians who are collaborating to transform the Hunter New England health system and deliver evidence into practice.
At the end of this session you will be able to:
- Explain Translational Research and how to inspire and empower delegates as “Translational Researchers”
- Describe the value of working in a collaborative alliance to drive system change
- Argue that by being part of the HealthPathways Community you are using the HealthPathways way of working to translate evidence into practice
The Power of Alliance: Transforming Health Together in Hunter and New England
Presenters: Jane Gray and Catherine Turner
In this session you will hear how our two organisations are collaborating to transform practice in rural and regional Australia. United by a wish to transform and improve the Hunter New England health system in line with the Quadruple Aim, our two organisations established an Alliance with nine elements:
- A formal agreement to partner
- An agreed way of prioritising and planning integrated care work together in an annual cycle
- Transparently holding ourselves accountable through a regular Integrated Care Alliance Executive meeting
- Agreed ways of using existing vehicles for involving clinicians
- Agreed ways of using existing vehicles for involving patients and families
- Agreed ways of sharing knowledge about “how we do things around here” with our entire clinical community
- Commitment to sharing data and using Patient Reported Outcome Measures (PROMS) to measure results from a patient perspective
- Clear programs for supporting aspiring change agents whose work meets our priorities
- Shared commitment to research and its translation
HealthPathways: Mobilising Evidence into Practice
Presenter: Dr Lee Fong
It is said to take an average of 17 years for health evidence to be translated into practice. HealthPathways can eliminate the long wait. It provides a practical vehicle for the swift translation of research evidence into practice because it can:
- bring clinical communities together to interpret new evidence immediately after publication and translate it to the desk of every clinician at point of care
- provide a baseline against which practice can be measured, thereby demonstrating unwarranted clinical variation
- clearly describe agreed local practice that can be added to other decision support tools, such as smart eReferral systems
Revisions to policies, procedure, law and practice, such as recent changes to the treatment of viral Hepatitis C (HCV) and prescribing of codeine, can be rapidly communicated in ways that support everyone in the health system to adapt quickly.
Healthy Kids: A Successful Population Health Approach
Presenter: Assoc Prof Luke Wolfenden
Reducing the risks of non-communicable disease in the community requires the implementation of evidence based interventions at scale. However, engaging health services and community organisations in the delivery of preventive interventions represents a considerable challenge. The aim of this presentation is to describe characteristics of effective approaches to population health service delivery at scale with an emphasis on the role of partnerships and delivery infrastructure. A number of case studies will be presented to with the key learnings from these initiatives discussed.
Working Together to Translate Research Into Practice - NSW Regional Partners Centre for Innovation in Regional Health
Presenter: Professor Maree Gleeson
In 2016, a postcode in Regional Australia was associated with a life expectancy reduction of one year for rural community dwellers and three years for those in remote communities. The regional life expectancy gap is even further exaggerated by up to 10 years for Aboriginal and Torres Strait Islander people. Regional health care is delivered by a complex web of interrelated and co-dependent services. Geographical dispersion creates additional challenges to service integration.
Australia is recognised for the quality of its biomedical and clinical research, yet this excellence is often not reflected in its implementation into clinical practices/outcomes, especially for communities in regional, rural and remote Australia, and particularly for Aboriginal and Torres Strait Islander people. Australians can be disadvantaged by this failure to turn discoveries and innovations into better health preventative strategies, new treatments, and better ways of caring for our communities.
NSW Regional Health Partners CIRH aims to help close this gap. We are working to truly integrate biomedical and clinical research, population health prevention strategies and healthcare provision to provide the best healthcare for people living in regional, rural and remote communities, with a flow on to all Australians.
NSW Regional Health Partners CIRH is a unique partnership between three Local Health Districts, a public hospital, a primary health care organisation, an independent medical research institute, and two regional universities; all of whom have made a commitment to deliver this vision of better healthcare outcomes. Together we are focusing on the translation of our outstanding research into treatments and models of care that will bring benefit to our patients, our communities and the opportunity of scalability
Return to the Conference Programme